//
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
21st Century CE: The New Iron Age?
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
Noninvasive Imaging for the Evaluation of Diastolic Function: Promises Fulfilled